Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More

Ardelyx Says Met With FDA In Type A Meeting But Was Not Provided Sufficient Clarity On What Constitutes ‘clinical relevance of the magnitude of treatment effect’; Awaits Additional Info Regarding Path For Tenapanor NDA

Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company focused on the discovery, development, and commercialization of innovative first-in-class medicines to improve treatment for people with kidney and cardiorenal

ARDX